Gregory R. Friberg, EVP, Chief R&D Officer: Biomarin Pharmaceutical BMRN Sell · Filed 02/26

Trade details

Type: Insider sale
Amount: $381,963.88
Shares · price: 6,326 sh · $60.38 a share
Held after: 37,578 sh
Stock: Biomarin Pharmaceutical BMRN
Person: Gregory R. FribergEVP, Chief R&D Officer
Trade date: 26/02/26
Filed: 26/02/26
Days to filing: 0 days

Sold 14.4% of holdings

Share of holding sold: 14.4%

Biomarin Pharmaceutical trades, last 26 weeks

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 01/27~03/28

Gregory R. Friberg's recent trades

Gregory R. FribergEVP, Chief R&D Officer
SellBiomarin Pharmaceutical
Sell
Biomarin Pharmaceutical
BMRN
$176.7K
3,281 sh
$176.7K
Filed 05/11
Traded 05/07
Gregory R. FribergEVP, Chief R&D Officer
Planned saleBiomarin Pharmaceutical
Planned sale
Biomarin Pharmaceutical
BMRN
$176.7K
3,281 sh
$176.7K
Filed 05/07
Traded 05/07
Gregory R. FribergEVP, Chief R&D Officer
Planned saleBiomarin Pharmaceutical
Planned sale
Biomarin Pharmaceutical
BMRN
$381.9K
6,326 sh
$381.9K
Filed 02/26
Traded 02/26